Australia markets close in 5 hours 17 minutes

Paradigm Biopharmaceuticals Limited (PBIGF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.1900+0.0107 (+5.97%)
At close: 01:46PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
-
46.76
79.224
20.55
-
Cost of revenue
-
18.827
143.751
99.138
-
Gross profit
-
27.933
-64.527
-78.588
-
Operating expenses
Research development
71,324
52,679
39,012
33,517
12,794
Selling general and administrative
5,520
6,565
7,934
8,748
4,167
Total operating expenses
77,248
60,066
47,926
43,312
17,173
Operating income or loss
-77,217
-60,039
-47,991
-43,391
-17,173
Interest expense
14.141
16.416
28.633
37.722
34.168
Total other income/expenses net
6,938
6,742
8,657
8,712
3,698
Income before tax
-69,001
-51,910
-39,250
-34,297
-12,299
Income tax expense
0
0
0
0
0
Income from continuing operations
-69,001
-51,910
-39,250
-34,297
-12,299
Net income
-69,001
-51,910
-39,250
-34,297
-12,299
Net income available to common shareholders
-69,001
-51,910
-39,250
-34,297
-12,299
Basic EPS
-0.18
-0.18
-0.16
-0.16
-0.06
Diluted EPS
-0.18
-0.18
-0.16
-0.16
-0.06
Basic average shares
289,678
289,678
240,964
212,192
208,266
Diluted average shares
289,678
289,678
240,964
212,192
208,266